Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
March 05 2015 - 10:32AM
Edgar (US Regulatory)
March 2015
|
|
|
|
|
Pricing Sheet dated March 3, 2015 relating to
Preliminary Terms No. 326 dated March 2, 2015 Registration Statement No. 333-199966 Filed pursuant to Rule
433 |
STRUCTURED INVESTMENTS
Opportunities in International Equities
PLUS Based on the Value of the EURO STOXX 50® Index due March 8, 2017
Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
|
|
|
|
PRICING TERMS —
March 3, 2015 |
|
|
| Issuer: |
|
JPMorgan Chase & Co. |
| Underlying index: |
|
EURO STOXX 50® Index |
| Aggregate principal amount: |
|
$20,130,000 |
| Payment at maturity: |
|
If the final index value is greater than the initial index value, for each $10 stated principal amount PLUS,
$10 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment at maturity.
If the final index value is less than or equal to the initial index value, for each $10 stated principal amount PLUS,
$10 × index performance factor
This amount will be less than or equal to the stated principal amount of $10 per PLUS. |
| Leveraged upside payment: |
|
$10 × leverage factor × index percent increase |
| Index percent increase: |
|
(final index value – initial index value) / initial index value |
| Initial index value: |
|
The closing level of the underlying index on the pricing date, which was 3,549.11 |
| Final index value: |
|
The closing level of the underlying index on the valuation date |
| Leverage factor: |
|
150% |
| Index performance factor: |
|
final index value / initial index value |
| Maximum payment at maturity: |
|
$18.00 (180.00% of the stated principal amount) per PLUS. |
| Stated principal amount: |
|
$10 per PLUS |
| Issue price: |
|
$10 per PLUS (see “Commissions and issue price” below) |
| Pricing date: |
|
March 3, 2015 |
| Original issue date (settlement date): |
|
March 6, 2015 |
| Valuation date: |
|
March 3, 2017, subject to postponement in the event of certain market disruption events and as described under “General Terms of Notes — Postponement of a Determination
Date” in the accompanying product supplement no. 4a-I |
| Maturity date: |
|
March 8, 2017, subject to postponement in the event of certain market disruption events and as described under “General Terms of Notes — Postponement of a
Payment Date” in the accompanying product supplement no. 4a-I |
| CUSIP / ISIN: |
|
48127T301 / US48127T3014 |
| Listing: |
|
The PLUS will not be listed on any securities exchange. |
| Agent: |
|
J.P. Morgan Securities LLC (“JPMS”) |
|
|
|
|
|
|
|
|
|
| Commissions and issue price: |
|
Price to public(1) |
|
Fees and commissions |
|
Proceeds to issuer |
| Per PLUS |
|
$10 |
|
$0.10(2) |
|
$9.875 |
|
|
|
|
$0.025(3) |
|
|
| Total |
|
$20,130,000 |
|
$251,625 |
|
$19,878,375 |
| (1) |
See “Additional Information about the PLUS — Supplemental use of proceeds and hedging” in this document for information about the components of the price to
public of the PLUS. |
| (2) |
JPMS, acting as agent for JPMorgan Chase & Co., will pay all of the selling commissions of $0.10 per $10 stated principal amount PLUS it receives from us to Morgan
Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”). See “Plan of Distribution (Conflicts of Interest)” beginning on page PS-87 of the accompanying product supplement no. 4a-I. |
| (3) |
Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.025 for each PLUS |
The estimated value of the PLUS on the pricing date as determined by JPMS was $9.799 per $10 stated principal amount PLUS. See “Additional Information about
the PLUS — JPMS’s estimated value of the PLUS” in the accompanying preliminary terms for additional information.
The PLUS are not
bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
You should read this document together with the preliminary terms describing the offering and the related product supplement no. 4a-I, underlying supplement no. 1a-I, prospectus supplement and prospectus, each
of which can be accessed via the hyperlinks below. Please also see “Additional Information about the PLUS” in the accompanying preliminary terms.
Preliminary terms no. 326 dated March
2, 2015: http://www.sec.gov/Archives/edgar/data/19617/000089109215001809/e63092fwp.htm
Product supplement no. 4a-I dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008407/e61359_424b2.pdf
Underlying supplement no. 1a-I dated November 7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008410/e61337_424b2.pdf
Prospectus supplement and prospectus, each dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008397/e61348_424b2.pdf
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you
should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web
site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free (800) 869-3326.
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Mar 2024 to Apr 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Apr 2023 to Apr 2024
